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Abstract
Bicaudal D1 (BICD1), an adaptor for the dynein‐dynactin motor complex, has been 
identified as a susceptibility gene in chronic obstructive pulmonary disease (COPD). 
Autophagy, an essential cellular homeostasis process, is defective in COPD, in 
which oxidative stress‐induced misfolded proteins accumulate into toxic aggregates 
dependent on the accumulation of the autophagic cargo receptor p62. Defective au-
tophagy can be caused by mutations in the dynein and dynactin motor complex sug-
gesting a possible link between BICD1 and defective autophagy in COPD. BICD1 
levels were measured in peripheral lung tissue from COPD patients together with 
markers of autophagy and found to be increased in COPD together with autophago-
somes, p62 and p62 oligomers. In vitro exposure of bronchial epithelial cells to 
cigarette smoke extracts (CSEs) revealed that high concentrations of CSE induced 
defective autophagosome maturation with accumulation of BICD1, p62 and ubiqui-
tin‐associated p62 oligomers. This was confirmed in vivo using CS‐exposed mice. 
Furthermore, we identified that formation of CS‐induced p62 oligomers required 
an interaction with Keap1. Overexpression and ablation of BICD1 confirmed that 
increased BICD1 negatively regulates autophagosome maturation inducing accumu-
lation of p62 and p62 oligomers and that it can be reversed by cardiac glycosides. We 
conclude that defective autophagosome maturation in COPD is caused by oxidative 
stress‐mediated BICD1 accumulation.
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1 |  INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is an age‐ 
related condition caused by oxidative stress, usually resulting 
from long‐term cigarette smoking or biomass smoke expo-
sure that, with no current drugs that can stop the progressive 
decline in lung function, is set to become the third leading 
cause of death worldwide.1
COPD has been associated with defective turnover of 
macromolecules damaged by oxidative stress that results 
in the accumulation of ubiquitinated protein aggregates 
(aggresomes). The association of aggresomes with the auto-
phagic cargo receptor p62 suggests defective autophagy in 
COPD lung;2-4 however, other studies suggest that excessive 
activation of autophagy is involved in apoptosis and alveolar 
destruction in emphysema.5-9
Macroautophagy (hereafter referred to as autophagy) is 
an evolutionary conserved lysosomal degradation process 
for the elimination and recycling of damaged or surplus 
cytosolic components. This process involves the sequestra-
tion of cytoplasmic proteins and organelles into a double 
membrane vesicle called the autophagosome.10 During the 
maturation step, autophagosomes fuse with lysosomes to 
form autolysosomes, where the final hydrolytic degrada-
tion of the engulfed cytoplasmic material takes place.10 
Distinct from the ubiquitin proteasome system (UPS), 
autophagy can selectively degrade large structures such 
as protein aggregates, intracellular bacteria, viral capsids, 
and protein aggregates.10,11 A more unselective, bulk auto-
phagy process is also induced by nutrient limitation. The 
formation of autophagosomes requires a well‐orchestrated 
activation of protein complexes that constitute the basal au-
tophagy apparatus.12 Among these autophagy‐related (Atg) 
proteins are the Atg8 family proteins, including microtu-
bule‐associated protein 1A/1B‐light chain 3 (LC3‐I) that, 
by conjugation to phosphatidylethanolamine, becomes 
LC3‐II and is integrated into autophagosomes.13 Selective 
autophagy receptors such as p62, NBR1, and NDP52 rec-
ognize ubiquitinated proteins and intracellular pathogens 
destined for autophagy and the cargo is directed toward de-
veloping autophagosomes where they bind LC3 via their 
LC3‐interacting regions.14 “Autophagic flux” is the term 
used to define the process of autophagosome synthesis (ini-
tiation), delivery of autophagic substrates to the lysosome 
and subsequent degradation of autophagic substrates inside 
the lysosome.15 Both the delivery of autophagosome to the 
lysosome and degradation are also called “autophagosome 
maturation.” The presence of autophagosomes can equally 
mean the activation of autophagy or defective autophago-
some maturation. The mTOR inhibitor, rapamycin, is an 
inducer of autophagy and therefore a potential drug for the 
restoration of defective autophagy in various diseases.16 
Whereas mTOR is involved primarily in the initiation steps 
of autophagy, the use of rapamycin for defects in autopha-
gosome maturation could be potentially detrimental as 
shown in a murine model of amyotrophic lateral sclerosis 
where treatment with rapamycin induced further accumu-
lation of protein aggregates and reduced cell viability.17,18 
Thus understanding the pathway involved in defective au-
tophagic flux is crucial for developing therapies to reverse 
pathological conditions such as COPD.
Kong et al19 recently identified in a genome‐wide associa-
tion study of emphysema an association of a single‐nucleotide 
polymorphism in bicaudal‐D1 (BICD1) with the presence or 
absence of emphysema. BICD1 is one of the two mammalian 
homologues of Drosophila bicaudal‐D1, acting as adaptor 
proteins that can regulate dynein‐based vesicle motility within 
the cytoplasm.20,21 BICD1 is involved in microtubule anchor-
age at the centrosome and the regulation of microtubular func-
tion.22 Autophagosomes move in the direction of lysosomes 
located near the centrosome by association with the dynein 
motor complex.23 Kong et al19 showed that the locus most 
highly associated with emphysema is in a region that covers 
the second exon of the gene BICD1 that encodes the sequence 
located in the coiled‐coil domain at the N terminus of the pro-
tein, which directly interacts with dynein. The role of BICD1 
in COPD and autophagy however remains unknown.
Our findings confirmed the presence of autophagosomes 
in lung tissue from COPD patients together with an accumu-
lation of p62 and p62 oligomers and total LC3, suggesting 
a defect in autophagosome maturation. We also show that 
BICD1 is increased in COPD lung and accumulation of this 
protein results in defective autophagosome maturation. We 
recapitulated these findings using an in vitro cigarette smoke 
(CS) model within a bronchial epithelial cell line and found 
that, accumulation of p62, p62 oligomers and autophago-
somes were observed at high concentrations of CS. In addi-
tion, p62 oligomers were found to be strongly associated with 
ubiquitinated substrates and that oligomerization depended 
on direct association with Keap1 during defective autopha-
gosome maturation. Finally, cardiac glycosides, but not rapa-
mycin, reversed the defective autophagosome maturation.
2 |  MATERIALS AND METHODS
2.1 | Reagents and antibodies
Chloroquine, ammonium chloride, digoxin, digoxigenin, 
strophanthidin, DAPI mounting media, rapamycin, 3‐(4,5‐di-
methylthiazol‐2yr)‐2‐5‐diphenyltetrazoliumbromide (MTT), 
actinomycin D, bafilomycin SMER28 and N‐acetylcysteine 
from Sigma (Poole, UK) were used.
Protein A magnetic beads were purchased from Thermo 
Scientific (East Riding of Yorkshire, UK). Antibodies against 
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the following were used for immunoblotting: p62 (rabbit poly-
clonal; #P0067), LC3 (rabbit polyclonal; #L8918), Ubiquitin 
(rabbit polyclonal; #SAB1306222), NBR1 (rabbit polyclonal, 
#SAB2107031) from Sigma. p62 (mouse monoclonal; # 
sc‐28359), caspase‐3 (rabbit polyclonal; #sc‐136219) from 
Santa Cruz Biotechnology. Beta‐actin (mouse monoclonal; 
#ab8226), GFP (#ab1218), and LAMP1 (rabbit polyclonal; 
#ab24170) from Abcam. Cleaved caspase‐3 (rabbit polyclonal; 
#9661) from Cell Signalling (New England Biolabs). Keap1 
(mouse monoclonal; #TA502059) and FLAG (mouse mono-
clonal; #TA50011‐100) from Origene).
2.2 | Cell culture
BEAS‐2B cells (human bronchial epithelial) (ATCC,) 
were cultured as previously described.24 BEAS‐2B cells 
were serum starved 24  hours before stimulation. Normal 
human bronchial epithelial cells (HBEC) were purchased 
from Lonza (Basel, Switzerland) and cultured as speci-
fied by the company. Human epithelial kidney cell line 
HEK293 cells (ATCC) were grown in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal calf serum 
supplemented with nonessential amino acids, 2  mmol/L 
L‐glutamine, penicillin (100  units/mL), and streptomycin 
(100 µg/mL). A549 cells (ATCC) were cultured as previ-
ously described.25 A549 cells were serum starved 24 hours 
before CSE treatment.
2.3 | Peripheral lung tissue
Peripheral lung tissue from four nonsmokers (healthy vol-
unteers) subjects with normal lung function, 10 smoker sub-
jects with normal lung function, eight subjects with GOLD 
stage 1 (mild), eight with stage 2 (moderate), four with stage 
3 (severe), and eight with stage 4 (very severe) COPD were 
obtained using a tissue bank linked to an established patient 
registry and kindly provided by Dr James Hogg and Dr Mark 
Elliot (University of British Columbia).26
2.4 | Plasmids and transfections
BEAS‐2B cells were transfected with siRNA for non-
specific oligonucleotide control (NC) and Keap1 (Life 
Technologies) using HiPerfect (Qiagen) for 48  hours or 
72  hours. HEK293 cells were transfected with different 
plasmids using Lipofectamine (Invitrogen). The following 
plasmids were characterized in a previous work by Lamark 
et al27: pDest‐EGFP‐p62 WT, pDest‐EGFP‐p62 ∆123‐170, 
pDest‐EGFP‐p62 ∆170‐256, pDest‐EGFP‐p62 ∆256‐370, 
pDest‐EGFP‐p62 ∆346‐385, pDest‐EGFP‐p62 (1‐385) that 
is ∆UBA (∆385‐440), pDest‐mCherry‐EGFP‐p62, pDest‐
mCherry‐EGFP‐LC3B, and pDest‐EGFP‐p62 E352A (KIR 
point mutant). pBABE‐puro mCherry‐EGFP‐LC3B were 
a gift from Ana Maria Cuervo and pEGFP‐LC3B was pur-
chased from Addgene.
2.5 | Quantification of autophagososmes and 
autolysosomes
HEK293 was transiently transfected with pBABE‐puro 
mCherry‐EGFP‐LC3B (500ng) using 1 µL of lipofectamine in 
100µl Opti‐MEM™ I Reduced Serum Medium (Invitrogen) 
for 48 hours. Cells were then incubated with LC‐CSE or HC‐
CSE for 5, 24, and 24 hours plus another 24 hours in fresh 
media without CSE (48  hours). Autophagosomes (Yellow 
color) and Autolysosomes (Red color) were quantified using 
CellProfiler.
2.6 | Preparation of cigarette smoke extracts
One full‐strength Marlboro cigarette with filter removed 
(Phillip Morris USA) was directed via a tube into 10 mL of 
serum‐free culture media using a peristaltic pump. Cigarette 
smoke extract (CSE) was then passed through a 0.2 µm filter 
to sterilize and remove particulate matter and was used im-
mediately. The optical density was measured at 320λ (OD 
0.85 ± 0.03). The concentration of CSE used was calculated 
as % v/v of CSE vs total volume of media.
2.7 | Western blotting and 
immunoprecipitation
Protein extracts were prepared using RIPA buffer (Sigma: 
150 mmol/L NaCl, 1.0% IGEPAL® CA‐630, 0.5% sodium 
deoxycholate, 0.1% SDS, and 50 mmol/L Tris, pH 8.0.) and 
completed with protease inhibitor (Roche, Welwyn Garden 
City, UK). N‐ethylmaleimide (NEM; 25  mmol/L, Sigma) 
was also added to the RIPA buffer for detecting ubiquitin 
linked to immunoprecipitation of p62. Immunoprecipitation 
was conducted with anti‐p62 in 300‐600  μg of whole‐cell 
lysate overnight at 4°C. Immunoprecipitates were captured 
with Protein A magnetic beads. After extensive washing, 
bound proteins were released by boiling in SDS‐PAGE sam-
ple buffer. Protein extracts (40  µg of immunoprecipitates) 
were analyzed by SDS‐PAGE (Invitrogen) and detected with 
Western Blot analysis by chemiluminescence (ECL Plus; GE 
Healthcare). Protein expression levels were expressed rela-
tive to β‐actin.
2.8 | Immunocytochemistry
BEAS‐2B and HEK293 cells were grown on poly‐L‐lysine 
coated glass coverslips in 24‐well plates. After experimen-
tal procedures, the cells were washed with PBS and fixed 
in 4% paraformaldehyde in PBS for 15  minutes. Cells 
were then washed twice with PBS and permeabilized with 
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ice‐cold methanol (−20°C, 10  minutes). BEAS‐2B cells 
were blocked in 5% (w/v) milk in PBS for 1 hour followed 
by 2 hours incubation with rabbit anti‐LC3 (1/50) and mouse 
LAMP1 (1/50) in 5% milk. After washing three times with 
PBS, cells were further incubated with Alexa fluor® 488 
Donkey Anti‐Rabbit (1/400) and APC anti‐mouse antibod-
ies (1/100) for 1 hour. Cells were then washed three times 
with PBS and mounted onto slides using Fluoroshield with 
DAPI. Confocal microscopy was performed using a Zeiss 
LSM‐510 microscope and the Zeiss LSM Image Browser 
software was used to generate images. In addition to single 
images, Z‐series stacks of 0.5  µm were taken in order to 
spatially resolve the position of autophagosomes within the 
cells using a 63X oil lens magnification. To visualize the 
XZ and YZ planes at a given point of the stack, orthogonal 
views were also taken. Quantification of total LC3 area per 
nuclei and the number of LC3 punctae per nuclei was as-
sessed using Image J analysis.
2.9 | Statistical analysis
Data are expressed as median ± SEM. Results were analyzed 
using t test and one‐ or two‐way ANOVA for repeated meas-
ures with Dunnett or Bonferroni posttests using the Graph 
Pad Prism Software (Prism). Clinical data were analyzed by 
Kruskal‐Wallis followed by Mann‐Whitney. P  <  .05 was 
considered statistically significant.
3 |  RESULTS
3.1 | BICD1, LC3‐II, p62, and total LC3 are 
increased in COPD lungs
Whole‐cell extracts were obtained from four healthy vol-
unteers (HV), 10 healthy smokers (SM), 16 patients with 
mild COPD (CD1/2; GOLD1 plus GOLD 2), and 12 severe 
COPD (CD3/4; GOLD3 plus GOLD4) (Table 1). HV data 
were not used in the statistical analysis due to low numbers. 
The expression of markers of autophagy LC3‐II, total LC3 
(I  +  II), and p62 was measured by Western blotting. As 
shown in previous studies,3,5,6 autophagosomes (LC3‐II) 
were significantly increased in CD3/4 patients compared 
to SM (P < .01), but also when compared to CD1/2 patients 
(P <  .01) (Figure 1A,B). Although CD1/2 also displayed 
high levels of LC3‐II, these were not significantly different 
compared to SM (P = .12) (Figure 1A,B). LC3‐II accumu-
lation measures the presence of autophagosomes whereas 
total LC3 (cytoplasmic LC3‐I and autophagosomal LC3‐
II) and p62 can indirectly indicate a defect in autophagy 
maturation.15 Total LC3 protein levels in CD3/4 patients 
were significantly increased compared to SM (P < .05) and 
CD1/2 (P < .05) (Figure 1A,C). The accumulation of LC3‐
II negatively correlated with % predicted FEV1 (forced ex-
piratory volume in 1 second) in COPD patients (r = −0.56; 
P  <  .005) (Table 2). The expression of p62 was signifi-
cantly increased in CD3/4 compared with SM (P  <  .01) 
T A B L E  1  Patient's profile
  HV SM COPD gold1/2
COPD
gold3/4
Age 55.6 ± 13.2 65.8 ± 4.0 65.2 ± 2.1 60.3 ± 1.7
Sex (M/F) 2/2 4/6 9/6 5/7
Smoking (pack‐year) 0 58 ± 10 56 ± 9 (n = 15) 46 ± 6 (n = 10)
pre‐FEV1 (L) 2.83 ± 0.40 2.42 ± 0.19 2.06 ± 0.16 0.79 ± 0.17 (n = 11)*** 
post‐FEV1 (L) 2.98 ± 0.49 2.57 ± 0.19 2.18 ± 0.16 0.86 ± 0.16*** 
pre‐FVC (L) 3.60 ± 0.60 3.36 ± 0.28 3.40 ± 0.25 1.99 ± 0.28 (n = 11)* 
post‐FVC (L) 3.71 ± 0.68 3.49 ± 0.27 3.56 ± 0.27 2.24 ± 0.28 (n = 11)* 
FEV1 (%pred) 98 ± 7 96 ± 5 76 ± 4 28 ± 5**** 
FEV1/FVC (%) 81 ± 2 74 ± 1 62 ± 2* 62 ± 3 (n = 11)**** 
PO2 (mmHg) 116 (n = 2) 107 ± 22 (n = 4) 105 ± 11 (n = 13) 63 ± 4 (n = 9)* ,a
O2SAT 0.98 (n = 2) 0.95 ± 0.02 (n = 4) 0.97 ± 0.01 (n = 13) 0.92 ± 0.03 (n = 5)
PCO2 (mmHg) 40.5 (n = 2) 43 ± 1 (n = 4) 48 ± 2 (n = 13) 53 ± 2 (n = 8)
HCO3 (mmol/L) 25 (=2) 23 ± 1 (n = 4) 25 ± 0.4 (n = 13) 28 ± 3 (n = 4)
PH 7.41 (n = 2) 7.3 ± 0.1 (n = 4) 7.3 ± 0.02 (n = 13) 7.4 ± 0.02 (n = 8)
Abbreviations: HV, healthy volunteers; SM, Non‐COPD smokers.
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and the increase in CD1/2 patients was also higher than 
smokers, although not significantly (P = .1) (Figure 1A,D). 
Interestingly, the expression of p62 negatively correlated 
with lung function by FEV1 (% predicted) in all COPD pa-
tients and only CD3/4 patients (Table 2). In addition, p62 
oligomers were increased in CD1/2 and CD3/4 compared 
to SM; however, these were not significant (Figure 1A,E). 
A positive correlation between smoking history as meas-
ured by pack years versus p62 oligomers were observed in 
all smokers and COPD patients (r = 0.54; P < .01) (Table 
2). CSEs have been shown to induce p62 and LC3 protein 
expression in bronchial epithelial cells28 so we compared 
the markers of autophagy between non/ex‐smokers versus 
current smokers (Figure S1). Our data suggest that current 
smokers do not display higher levels of LC3 and p62 ex-
pression as compared to nonsmokers.
We observed a significant increase in BICD1 in CD1/2 and 
CD3/4 as compared to SM (Figure 1A,F). BICD1 positively 
correlated with p62 monomers (r = 0.76, P < .0001) (Figure 
1G) and was close to significance with total LC3 (r = 0.31, 
P  <  .055) (Figure 1H). In addition, BICD1 negatively cor-
related with lung function by FEV1 (% predicted) in all COPD 
patients and only CD3/4 patients (Table 2). Together these data 
suggest that although autophagosomes are increased as COPD 
severity progresses, this might be due to a defect in autophago-
some maturation resulting in increased total LC3 and p62 to-
gether with evidence of p62 oligomer formation. Our data also 
suggest that an increase in BICD1 in milder CD1/2 precedes 
F I G U R E  1  Increased p62, LC3‐II, total LC3, and BICD1 proteins in chronic obstructive pulmonary disease (COPD) patients. Lung tissue 
from surgical resections were obtained from four healthy volunteers (HV), 10 non‐COPD smoker volunteers (SM), 16 mild CD1/2 (COPD GOLD 
stage 1 plus GOLD stage 2), and 12 severe CD G3/4 (COPD GOLD stage 3 plus GOLD stage 4) and whole cell extracts were prepared for Western 
blot. (A) Representative blot. Ct: Control whole cell extract from BEAS‐2B cells. Immunoblotting for p62, LC3‐II, and BICD1 were performed 
and relative protein amounts were calculated and plotted on a graph against β‐actin: (B) LC3‐II, (C) LC3‐I + LC3‐II (total LC3) (D) p62, (E) p62 
oligomers, and (F) BICD1. (G) Correlation between p62 and BICD1 in all patients. (H) Correlation between total LC3 and BICD1 in all patients. 
Data were analyzed by using Kruskal‐Wallis followed by Mann‐Whitney. P < .05 was considered statistically significant. *P < .05, **P < .01. 
Whole cell extracts from BEAS‐2B cells were used as control (Ct) in the Western blot membrane
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the accumulation of p62 and total LC3 observed in more severe 
CD3/4.
3.2 | Cigarette smoke impairs 
autophagic clearance of p62 oligomers and 
autophagosomes
In order to understand how cigarette smoke exposure affects 
the autophagic process in the lung, bronchial epithelial cells 
(BEAS‐2B cells) were incubated with increasing concentra-
tions of CSE and markers of autophagy (LC3‐II, total LC3, 
and p62) were assessed by Western blotting. CSE induced a 
concentration‐dependent increase in autophagosomes (LC3‐
II) 24 hours postexposure (visible from CSE 7.5%) (Figure 
2A). As previously observed in COPD patients, CSE also in-
duced a concentration‐dependent increase in p62 oligomers 
which were resistant to the reducing conditions of the SDS‐
PAGE (Figure 2A). This increase in p62 oligomers correlated 
with an increase in total LC3. At higher concentrations of 
CSE (HC‐CSE [9%‐10%]), the increase in total LC3 and p62 
oligomers are particularly visible (Figure 2A), suggesting a 
defect in autophagy maturation at high concentration of CSE 
only. CSE induced a concentration‐dependent decrease in 
cell viability with a maximum of 34% at HC‐CSE (P < .001) 
(Figure S2). An increase in cleaved caspase‐3 at HC‐CSE but 
not with lower CSE concentration suggests that apoptosis 
could be responsible for the reduction in cell viability ob-
served (Figure S3). In order to compare a CSE concentration 
that induces autophagy versus a concentration that seemed to 
induce defective autophagic flux, BEAS‐2B cells were ex-
posed to low concentration of CSE (LC‐CSE or 3.3%) and 
high concentrations (HC‐CSE or 10%) for 1, 5, 24 hours, and 
an additional time point 24  hours after washing cells with 
PBS and incubating with fresh media (48 hours). Both LC‐ 
and HC‐CSE induced autophagy (1‐5  hours) as shown by 
the conversion of LC3‐I to LC3‐II, suggesting an increase 
in LC3‐II incorporation into autophagosomes (Figure 2B,C). 
Whereas LC‐CSE induction of LC3‐II goes back to baseline 
levels at 24 hours, the increase in autophagosomes by HC‐
CSE is further increased with time, despite the CSE stimulus 
having been removed (48 hours) (Figure 2B,C). These find-
ings were confirmed using confocal microscopy by detection 
of autophagosomes using a specific antibody against LC3 
which was conjugated to GPF (Figure 2E). Anti‐LAMP1 was 
used to localize lysosomes (conjugated to Alexa Fluor 594) 
(Figure 2E). LC‐CSE induced autophagosomes (LC3 punc-
tae and total LC3 area), peaking at 24 hours and returning to 
baseline levels after cells were washed and incubated in fresh 
media after 24 hours (48 hours time point) (Figure 2E). HC‐
CSE also induced autophagosomes; however, these failed to 
return to basal levels as shown at the 48 hours time point as 
compared to NT (total LC3 area and LC3 punctae) (Figure 
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that were not cleared even 48 hours posttreatment, suggest-
ing a lack of autophagosome clearance as a result of defec-
tive autophagosome maturation. In addition to p62 monomer 
accumulation, CSE also induced a concentration‐dependent 
increase in p62 oligomers that were resistant to the reduc-
ing conditions of SDS‐PAGE (Figure 2B). Similar to LC3‐II, 
LC‐CSE induced p62 oligomers that peaked at 5 hours and 
returned to basal levels at 24  hours. At HC‐CSE, p62 oli-
gomers peaked between 5 hours and 24 hours but remained 
elevated at 48 hours (Figure 2B). p62 monomers were also 
increased at 24 hours and 48 hours time points. Preincubation 
with the antioxidant N‐acetyl cysteine (NAC, 10  mmol/L) 
totally prevented CSE‐induced p62, p62 oligomers, LC3‐II, 
and accumulation of total LC3, thus demonstrating that oxi-
dants present in CSE are responsible for autophagy induction 
and accumulation of autophagic adaptors (Figure S4).
3.3 | CSE impairs the autophagic flux by 
inhibiting autophagy maturation
LC3‐II is normally present at either side of the double 
membrane of autophagosomes. LC3‐II present inside the 
F I G U R E  2  Increased p62, LC3‐II, and total LC3 in bronchial epithelial cell line (BEAS‐2B) treated with cigarette smoke extract (CSE). 
(A) Whole‐cell extracts from BEAS‐2B cells that were treated with increasing concentration of CSE (3.3%‐10% v/v) for 24 h were analyzed by 
immunoblotting for LC3, p62, and β‐actin, n = 3 (B) Whole‐cell extracts from BEAS‐2B cells treated with a low and high concentration of CSE 
(LC‐CSE (3.3% v/v) and HC‐CSE (10% v/v)) at increasing time points (1‐48 h) and analyzed by immunoblotting for LC3, p62, and β‐actin, n = 4. 
(C) Autophagosomes (AP) formation was assessed by LC3‐II vs β‐actin from (B) and plotted. (D) Total LC3 proteins levels were assessed against 
β‐actin from (B). For (C) and (D) statistical analysis was performed using two‐way ANOVA for repeated measures with Bonferroni posttests.  
* P < .05, ** P < .01, *** P < .001. (E) APs were detected by confocal microscopy using a rabbit anti‐LC3 antibody conjugated to 488 Donkey 
Anti‐rabbit and lysosomes were detected by using mouse anti‐LAMP1 antibody conjugated to anti‐mouse APC. DAPI was used to visualize nuclei. 
Cells were incubated with CSE as described in (B) Scale bar: 10 μm. Statistical analysis was performed by comparing HC (*) and LC‐CSE ($) vs 
NT control P < .05, P < .01, P < .0001. Data are expressed as median ± SD of n = 3. * means comparing NT vs HC-CSE; * P < .05, ** P < .01, 
*** P < .001. (F) An “LC3 turnover” assay was performed by incubating BEAS‐2B cells with LC‐CSE and HC‐CSE for 19 hours plus 5 hours 
in the presence of ammonium chloride (AC, left graph, 10mM) or chloroquine (CQ, right graph, 100 µmol/L). The amount of LC3‐II was plotted 
against β‐actin. Data are expressed as median ± SEM
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autophagosome is digested with the internal cargo whereas 
LC3‐II present outside is recycled back into LC3‐I in the 
cytoplasm. If the autophagic flux is impaired at the matu-
ration step, total levels of LC3 (LC3‐I  +  LC3‐II) are in-
creased due to newly synthesized LC3 and a lack of LC3‐II 
degradation.29 After exposure to HC‐CSE, total LC3 was 
significantly increased at 24 hours and 48 hours compared 
to LC‐CSE and control suggesting defective autophagy 
maturation (Figure 2B,D). An “LC3 turnover” assay was 
performed in order to assess the autophagic flux at the 
 initiation step. In the presence of the lysosomotropic com-
pounds ammonium chloride (AC) or chloroquine (CQ) for 
5  hours, baseline autophagic flux can be observed by an 
accumulation of autophagosomes (LC3‐II) (Figure 2F). 
Accumulation of autophagosomes still happens when cells 
were treated with LC‐CSE for 24 hours plus 5 hours with 
lysosomotropic compounds (Figure 2F). Interestingly, de-
spite high levels of HC‐CSE‐induced LC3‐II, autophago-
somes are still being formed suggesting that the early 
steps of the autophagic flux (initiation) are fully functional 
(Figure 2F). These findings were confirmed when using the 
inhibitor of lysosome to autophagosome fusion, bafilomy-
cin, for 2 hours after HC‐CSE treatment (Figure S5). Our 
data imply that cells treated with HC‐CSE could be defec-
tive in autophagosome maturation such as the binding of 
autophagosomes to lysosomes to form autolysosomes. In 
order to detect if autolysosmes were visible in CSE‐incu-
bated cells, BEAS‐2B cells were co‐stained with LAMP1 
(lysosomal marker) and LC3 (Figure 2E); however, no co‐
localization was observed. We also transiently transfected 
HEK293 cells with p62‐FLAG and GFP‐LC3 plasmids in 
order to optimize CSE concentrations that recreated normal 
CSE‐induced autophagy activation and CSE‐induced de-
fective autophagic flux (Figure 3A). LC‐CSE induced LC3‐
II and p62 oligomer accumulation 24 hours posttreatment, 
and, as seen in BEAS‐2B, these were partially reduced 
24 hours after the CSE stimulus was removed (48 hours). 
In contrast, HC‐CSE strongly induced p62 oligomer accu-
mulation at 24 hours, and this increase continued even after 
the CSE stimulus was removed (48 hours) (Figure 3A). p62 
monomers were also increased. As expected, autophago-
some (LC3‐II) formation followed a similar trend, with an 
F I G U R E  3  Evidence of defective autophagosome maturation in CSE‐treated HEK293 cells. (A) HEK293 cells were transfected with p62‐
FLAG and LC3‐GFP and incubated with low or high CSE (LC‐CSE and HC‐CSE) for 24 h. Cells were washed and incubated with fresh media 
without CSE for another 24 h (48 h). Whole‐cell extracts were resolved by Western blot and immune‐stained against GFP and FLAG. (B) HEK293 
cells were transfected with GFP‐mCherry‐LC3 plasmid and incubated with LC‐CSE or HC‐CSE for 5 h, 24 h, and 24 h plus another 24 h in fresh 
media without CSE (48 h). GFP and mCherry were visualized by confocal microscopy. DAPI was used as a nuclear control. Scale bar: 10 μm. 
The ratio of autophagosomes vs autolysosomes (AL/AP) was calculated and plotted. HC‐CSE vs NT at 48 h; P = .07 (C) HEK293 cells were 
transfected with GFP‐mCherry‐LC3 plasmid incubated with CQ for 5 h. Data are representative of three independent experiments
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accumulation at 24 hours that was further increased after 
24 hours in fresh media (Figure 3A). This was associated 
with an overall increase in total LC3 protein (Figure 3A). 
Thus, HC‐CSE induced defective autophagy maturation 
in transfected HEK293 cells. In order to confirm if defec-
tive autophagy maturation could be visualized by micros-
copy, HEK293 cells were transiently transfected using a 
GFP‐mCherry‐LC3 tandem construct. Using this construct, 
autophagosomes and autolysosomes were labeled with yel-
low (mCherry and GFP) and red (mCherry only) signals, 
respectively. If autophagy is activated, both yellow and red 
punctae are increased. However, if autophagosome matu-
ration into autolysosomes is blocked, only yellow punc-
tae are increased without a concomitant increase in red 
punctae.  We observed that at LC‐CSE autophagosomes 
were visible (yellow punctae) after 5  hours incubation 
and that they progressively became autolysosomes (red 
punctae) over time (24‐48 hours) (Figure 3B). HC‐CSE in-
duced greater autophagosomes formation (yellow punctae, 
5 hours) that remained constant over time with little evi-
dence of autophagosome conversion to autolysosomes (red 
punctae) (Figure 3B). Quantification of autophagosomes 
(AP, yellow punctae) and autolysosomes (AL, red punc-
tae only) suggest a persistence of autophagosomes over 
autolysosomes (Figure 3B; graph) as compared to control 
and similar to CQ after 5  hours. HC‐CSE induced some 
large structures that could not be autophagosomes. These 
likely represent p62 aggregates that have recruited GFP‐
mCherry‐LC3. It has previously been shown that p62 can 
recruit GFP‐LC3 into protein aggregates in an autophagy‐
independent manner.30 Interestingly, when HEK293 cells 
were incubated with chloroquine, to inhibit the binding of 
autophagosome to lysosome, the continuous presence of 
autophagosomes was observed, similar to the treatment 
with HC‐CSE (yellow punctae) (Figure 3C). Hence, a 
lack of autolysosome formation suggests that autophago-
somes are unable to bind lysosomes after incubation with 
high concentration of CSE resulting in malfunctioning au-
tophagic flux by defective autophagosome maturation.
3.4 | Impairment of autophagic 
clearance of LC3 and p62 oligomers by high 
concentration of CSE confirmed in primary 
human bronchial epithelial cells
We confirmed these observations in primary HBECs. HBECs 
were incubated with LC‐CSE and HC‐CSE for a period of 
1, 5, and 24 hours and a further 24 hours in minimal media 
without CSE (48  hours). At both concentrations of CSE, 
early LC3‐II was observed (1‐5 hours) with marked increase 
in p62 oligomers after 5  hours exposure (Figure 4). After 
24  hours incubation both LC‐CSE and HC‐CSE induced a 
strong accumulation of LC3‐II, total LC3, and p62 oligomers 
(Figure 4). However, at the 48 hours time point, basal levels 
of LC3 and p62 oligomers were observed with LC‐CSE sug-
gesting a resolution of autophagy and subsequent clearance 
of autophagososmes. On the contrary, cells incubated with 
HC‐CSE showed a continuous presence of p62 oligomers 
and LC3‐II and increased total LC3 at 48 hours, suggesting 
impaired autophagic flux (Figure 4).
3.5 | CSE‐induced p62 oligomers depend 
on the Keap1 interacting region
p62 acts as a cargo receptor for the autophagic degradation 
of ubiquitinated substrates. p62 contains an N‐terminal PB1 
domain that allows polymerization, a LIR motif interact-
ing with LC3, a C‐terminal UBA domain that interacts with 
ubiquitin and a Keap1 interacting region (KIR) that inter-
acts with Keap1 thus controlling Keap1 stability (Figure 
5D).31,32 CSE‐induced p62 oligomers, that are resistant to 
SDS‐PAGE reducing conditions, have been observed in 
macrophages from smokers and after hydrogen peroxide 
treatment.33,34 The characteristics of these oligomers, their 
role in the flux of autophagy and the amino acid sequence 
of p62 that is responsible for the oligomer formation re-
main unknown. Endogenous p62, immunoprecipitated from 
BEAS‐2B cells that were incubated with HC‐CSE, dis-
played association with polyubiquitinated substrates (Figure 
F I G U R E  4  Defective autophagosome maturation in CSE‐treated primary human bronchial epithelial cells. HBECs from a healthy volunteer 
were treated with low or high CSE (LC‐CSE (20% v/v) and HC‐CSE (30% v/v)) at increasing times (1‐48 h) and analyzed by immunoblotting for 
LC3, p62, and β‐actin. At the 48 h time point, cells were washed and incubated with fresh media without CSE
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5A). The UBA region of p62 is known to bind polyubiq-
uitin and is needed to form cytoplasmic bodies.35 p62 was 
also associated with LC3‐II at baseline levels, possibly as 
part of the basal autophagic flux. After HC‐CSE incubation, 
binding did not increase despite the presence of more LC3‐
II (Figure 5A). Interestingly HC‐CSE also induced binding 
to cytoplasmic LC3‐I (Figure 5A). This is consistent with 
the recruitment of GFP‐mCherry‐LC3 to p62 aggregates 
F I G U R E  5  CSE induces p62 oligomers via their Keap1 interaction region (KIR). (A) BEAS‐2B cells were incubated with HC‐CSE for 
24 hours and p62 was immunoprecipitated (IP) from whole‐cell extracts. IP‐p62 species were resolved by SDS‐PAGE followed by Western blot 
(WB) and membranes immune‐stained against ubiquitin (Ub), LC3, and p62. IgG control (no whole‐cell lysates used). (B) Molecular weight 
characterization of p62 oligomers. HEK293 cells were transfected with p62‐FLAG and incubated with HC‐CSE for 24 h. Whole‐cell extracts 
were resolved by WB and immune‐stained against FLAG. A molecular marker for high molecular weights (MW) was used. A graph extrapolating 
distance of bands from origin and MW determined the expected size of p62 oligomers and the possible combinations. (C) Deubiquitination assay 
of IP‐p62. BEAS‐2B cells were prepared as indicated in (A). Samples were divided by two and p62 was IP. IP‐p62 beads were incubated in 
deubiquitin buffer plus/minus Ubiquitin specific peptidase 2 (USP2). (D) Schematic representation of p62 functional domains: PB1, ZZ (ZZ‐type 
zinc finger domain), LIR, KIR, and UBA and schematic representation of the different deletion p62 mutants used in (E). (E) HEK293 cells were 
transfected with either WT p62‐GFP, or the following p62‐GFP deletion plasmids: ∆123‐170, ∆170‐256, ∆256‐370, ∆346‐385, and ∆UBA 
(∆386‐440) and incubated with HC‐CSE for another 24 h. WB was performed and membranes were immune‐stained using anti‐GFP and β‐actin. 
(F) BEAS‐2B cells were transfected with siRNA for Keap1 or a random oligonucleotide control (NC) and incubated with LC‐ and HC‐CSE for 
a further 24 h. WB was performed and membranes were immune‐stained using against p62, LC3, Keap1, and β‐actin. (G) HEK293 cells were 
transfected with either WT p62‐GFP or a KIR deletion p62‐GFP plasmid and incubated with HC‐CSE for another 24 h. WB was performed and 
membranes were immune‐stained using anti‐GFP and β‐actin. Data are representative of at least two independent experiments
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seen in Figure 3B. NBR1 is another autophagy adaptor that 
contains a PB1 domain allowing heteropolymerization with 
p62. We found that p62 is associated with NBR1 but that 
the association was not increased after HC‐CSE incubation. 
In fact, NBR1 neither form SDS‐PAGE‐resistant oligomers, 
nor did it accumulate like p62 (Figure S6). Using 3%‐8% 
Tris‐acetate gels and a higher molecular weight ladder, we 
separated FLAG‐p62 that were overexpressed in HEK293 
cells in order to predict the size of the oligomers induced by 
CSE. Despite FLAG's molecular size of 13kDa, p62 mono-
mer was found at 62.5kDa mark (Figure 5B). In total six 
p62 oligomers were identified as possible dimers, trimers, 
tetramers, hexamers, and heptamers (Figure 5B). Incubation 
of IP‐p62 from CSE‐treated BEAS‐2B cells with the deu-
biquitinase USP2 also showed that deubiquitination did not 
result in reduced CSE‐induced p62 oligomers but reduced 
p62 association with ubiquitinated substrates (Figure 5C). 
In order to map the amino acid region of p62 involved in 
oligomer formation we used different GFP‐p62 deletion 
plasmids that were expressed in HEK293 followed by in-
cubation with CSE (Figure 5E). As p62 expression changed 
according to the functional domain being deleted, we as-
sessed p62 oligomer formation as p62 dimer versus mon-
omer (Figure 5E). We found that deletion of amino acids 
170 to 256 (Δ170‐256) actually increased dimer formation 
at baseline (about eightfold) and that deletion of the UBA 
(Δ386‐440) domain induced p62 dimer formation by about 
threefold. CSE induced p62 dimers by about 30‐fold in WT 
GFP‐p62. CSE also further induced GFP‐p62 (Δ170‐256) 
dimer formation compared to WT (by 60%). Interestingly, 
GFP‐p62 deletion plasmids Δ346‐385 and particularly 
Δ256‐370 prevented CSE‐induced dimer formation sug-
gesting that one or more amino acids contained in these 
sequences are important for oligomer formation. Both GFP‐
p62 Δ346‐385 and Δ256‐370 have in common the amino 
acid deletion sequence between 346 and 370 that includes 
the KIR (344‐356). This region is important for p62 direct 
association with Keap1 and subsequent autophagy‐medi-
ated degradation. It is possible that amino acids contained 
in the KIR are responsible for CSE‐induced p62 oligomers. 
A549 lung cancer cell line, which harbors mutated Keap1 
(G333C), is unable to bind to p62.36 We found that CSE 
only mildly induced p62 dimer formation in A549 cells, but 
did not induce any oligomers despite increasing LC3‐II and 
also LC3‐I at the highest concentrations (Figure S7). The 
importance of p62 interaction with Keap1 was confirmed by 
knocking down Keap1 in BEAS‐2B cells and looking at the 
effect on CSE‐induced p62 oligomers. Ablation of Keap1 
reduced CSE‐induced oligomers and monomers (Figure 
5F). Confirmation was obtained by looking at the effect of 
HC‐CSE on GFP‐p62 KIR mutant in HEK293 cells. CSE‐
induced oligomers were dramatically decreased in HEK293 
expressing the p62 KIR mutant (Figure 5G).
3.6 | BICD1 expression is involved in 
defective autophagosome maturation
Having identified an increased BICD1 expression in COPD 
biopsies which was associated with p62 expression (Figure 
1), we investigated the role of BICD1 as a possible protein in-
volved in defective autophagy maturation. We looked at the 
concentration‐dependent effect of CSE on BICD1. Although 
two bands were visible, an increase in the lower band only 
happened when concentrations of CSE reached 10% (Figure 
6A). This correlated with evidence of impaired autophagic 
flux (increased LC3 and p62 oligomers) (Figure 6A). In ad-
dition, HC‐CSE‐induced BICD1 was observed only at 24 and 
48 hours time points, when autophagosome maturation was 
defective (Figures 6B and 2B). Defective autophagic flux 
could be responsible for BICD1 accumulation, hence when 
BICD1 was knocked down (KD) and cells incubated with 
increasing concentrations of CSE (3.3%‐10%), the accumula-
tion of p62 oligomers was actually decreased as compared 
to random oligonucleotide control (RO) thus suggesting that 
BICD1 is a negative regulator of autophagy (Figure 6C). 
siRNA treatment increased LC3‐II levels so we used p62 to 
assess autophagy (Figure 6C). Interestingly, BICD1 knock-
down only reduced the lower of the two bands observed thus 
identifying the lower band as BICD1 protein (Figure 6C). 
Overexpression of BICD1, as compared to an empty vector 
(EV), confirmed that BICD1 plays a role in impairing au-
tophagic flux as CSE‐induced p62 oligomers were visibly 
increased (Figure 6D). LC3‐II levels were clearly increased 
with overexpressed BICD1 as compared to EV possibly 
suggesting a complete impairment of the autophagic flux 
(Figure 6D). Preincubation with the antioxidant NAC totally 
prevented CSE‐induced p62, p62 oligomers, LC3‐II, and ac-
cumulation as shown in Figure S4. We also established that 
NAC prevented an increase in BICD1 protein levels (Figure 
6E). In fact, BICD1 expression was induced by CSE at the 
gene expression level (Figure 6F). Furthermore, pretreatment 
with actinomycin D reduced HC‐CSE‐induced BICD1 pro-
tein expression and prevented LC3‐II as well as reduced p62 
monomers and oligomers thus averting defective autophago-
some maturation (Figure S8).
3.7 | p62, LC3, and BICD1 are increased 
in the lungs of CS‐exposed mice
As shown in Figure 7A,B, p62 monomers accumulated 
in the lungs of mice that were exposed chronically to CS 
although no evidence of p62 oligomers was visible. CS 
also induced LC3‐II suggesting that autophagosomes are 
present in the lung tissue (Figure 7A,C). Overall LC3 ex-
pression was also significantly increased, as observed in 
COPD, thus suggesting a possible block in autophagy mat-
uration (Figure 7A,D). In agreement with the data observed 
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in COPD biopsies and HC‐CSE experiments, the protein 
levels of BICD1 were significantly increased in all CS‐ex-
posed mice (Figure 7A,E).
3.8 | Cardiac glycosides reverse defective 
autophagosome maturation
In order to reverse defective autophagic flux caused by inef-
fective autophagy maturation, the effect of cardiac glycosides, 
previously identified as possible inducers of autophagosome 
maturation,37,38 was investigated and compared to rapamy-
cin. BEAS‐2B cells, preincubated with the cardiac glycosides 
strophanthidin (SP), digoxin (D), and digoxigenin (DG) (all 
at 100 ng/mL) prior to HC‐CSE, prevented p62 oligomer for-
mation and an increase in p62, and also reduced HC‐CSE‐
induced BICD1 (Figure 8A). In contrast, rapamycin did not 
prevent induction of p62 and p62 oligomers (Figure 8A). In 
addition, rapamycin (20  µmol/L), which increased LC3‐II, 
did not reduce BICD1 levels and even further increased p62 
expression (Figure 8A). The effect of cardiac glycosides on 
autophagic induction by LC3‐II formation was not clear and 
further investigated using an LC3‐turnover assay. The “LC3‐
turnover” assay was performed using CQ in order to see the 
effects of a digoxin on the autophagic flux. We showed that 
under defective autophagic flux (CQ treatment) digoxin did 
not further increased LC3‐II with or without HC‐CSE sug-
gesting that autophagy initiation is not activated by cardiac 
glycosides (Figure 8B). We also confirmed that despite 
LC3‐II accumulation by HC‐CSE, this is further increased 
after CQ treatment suggesting that initiation of autophagy is 
not affected by HC‐CSE as shown in Figure 2 (Figure 8B). 
Interestingly, HC‐CSE‐induced p62 (P < .05) is not signifi-
cantly upregulated with digoxin preincubation suggesting 
that autophagosome maturation restoration must be involved 
as autophagosomes are not induced by digoxin (Figure 8B). 
Whereas CQ treatment shows a significant increase in au-
tophagosomes (LC3‐II), it is not the case for p62 suggest-
ing that baseline autophagy in BEAS2B cells turns over p62 
slowly (Figure 8B). We confirmed that digoxin significantly 
reduced HC‐CSE‐induced BICD1 implying that cardiac 
F I G U R E  6  CSE induces BICD1 thus inhibiting autophagosome maturation. (A) Whole‐cell extracts from BEAS‐2B cells were treated with 
increasing concentrations of CSE (1.5%‐10% v/v) for 24 h and analyzed by immunoblotting for LC3, p62, BICD1, and β‐actin. The BICD1, p62, 
and β‐actin pictures were obtained from a 3%‐8% Tris‐acetate gel. The LC3 and (lower) β‐actin pictures were obtained from the same samples but 
using a 4%‐12% Bis‐tris gel. (B) Whole‐cell extracts from BEAS‐2B cells treated with LC‐ and HC‐CSE at increasing times (1‐48 h) and analyzed 
by immunoblotting for BICD1 and β‐actin. (C) BEAS‐2B cells were transfected with siRNA for BICD1 for 48 h or a random oligonucleotide 
control (NC) and incubated with increasing concentrations of CSE for a further 24 h. Western blot was performed and membranes were immune‐
stained against p62, LC3, BICD1, and β‐actin. (D) BEAS‐2B cells were transfected either with an empty mCherry vector (EV) or with a mCherry‐
BICD1 plasmid prior to incubation with increasing concentrations of CSE for a further 24 h. Western blot was performed and membranes were 
immune‐stained against LC3, BICD1, p62, and β‐actin. Data are representative of at least two independent experiments. (E) BEAS‐2B cells were 
preincubated with NAC (10 mmol/L) for 30 min prior to stimulation with LC‐ and HC‐CSE for 24 h. Western blot was performed and membranes 
were immune‐stained against BICD1, p62, and β‐actin. N = 3, *P < .05, ****P < .0001 using ANOVA with multiple comparisons. (F) BEAS‐2B 
cells were treated with HC‐CSE (10%) for 24 h. mRNA expression of BICD1 was determined and normalized to GNB2L1 mRNA levels. **P < .01
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glycosides restore autophagosome maturation by decreas-
ing BICD1 expression (Figure 8B). Interestingly, despite an 
increase in BICD1 mRNA transcripts by HC‐CSE, digoxin 
does not affect BICD1 transcription levels (Figure 8C).
We confirmed our findings in HBECs where preincuba-
tion with increasing concentrations of digoxin (1‐25 ng/mL), 
but not with rapamycin, prevented HC‐CSE‐induced p62 
monomer and oligomer accumulation in addition to partly 
restoring baseline levels of CSE‐induced LC3 (Figure 8D). 
CSE also induced a concentration‐dependent increase in 
BICD1 (lower band) that was reduced by preincubation with 
digoxin (Figure 8E).
An increase in total LC3 and LC3‐II has been associ-
ated with autophagic‐induced apoptosis and emphysema via 
caspase‐3 activation.6 We showed that cardiac glycosides 
completely inhibited HC‐CSE‐induced cleaved caspase‐3 
whereas rapamycin only partially prevented this (Figure 
S9). Interestingly, SMER28, a compound known to induce 
the clearance of mutant huntingtin fragments independent of 
mTOR inhibition, also cleared p62 oligomers (Figure S10).39 
SMER28 also prevented HC‐CSE‐induced cleaved caspase‐3 
as did strophanthidin but not rapamycin (Figure S10). Also, 
SMER28 treatment did not reduce BICD1 protein supporting 
the concept of a different mechanism of action (Figure S11).
4 |  DISCUSSION
Increasingly, defects in autophagosome maturation are 
being associated with various pathologies, particularly in 
neurodegenerative disorders such as Alzheimer's disease, 
Hungtington's chorea, and Parkinson's disease.40 In addition, 
defective autophagosome maturation has been associated with 
the aging of the human vascular system, as demonstrated by 
accumulation of autophagosomes (LC3‐II) with increased 
total LC3 levels as well as p62.41 Recently, aggresome bodies 
have been described in the lung of COPD patients, together 
with LC3‐II and p62.2,3 We have confirmed that patients suf-
fering from COPD show elevated levels of p62, LC3, and 
LC3‐II, suggesting that increased presence of autophago-
somes is not indicative of high level activation of autophagy 
but on the contrary, the result of defective autophagosome 
maturation. Our in vitro data using bronchial epithelial cells 
that were treated with the main causative factor of COPD, 
cigarette smoke support this hypothesis. CSE activated the au-
tophagy via an oxidative stress mechanism possibly involving 
cysteine protease Atg4 inhibition allowing LC3‐I to be con-
verted into LC3‐II.42 An increase in LC3‐II with low concen-
tration of CSE was not followed by a decreased p62 protein 
levels possibly due to the fact that oxidative stress induces p62 
transcription levels as shown recently.43 Only at higher con-
centration of CSE did we see a partial reduction of p62 protein 
5 hours after incubation. This might represent a state where 
the degradation of p62 by autophagy was higher than the rate 
of p62 transcription. High concentrations of CSE induced ac-
cumulation of total LC3, p62, and p62 oligomers even after 
cells were washed and incubated in fresh media. This was as-
sociated with persistent presence of autophagosomes as ob-
served in diseases associated with defective autophagosome 
maturation and in COPD. On the contrary, a lower concen-
tration of CSE only induced transient activation of LC3‐II 
and p62 oligomers that returned to baseline levels over time. 
Autophagosome maturation includes the binding between au-
tophagosomes and lysosomes to form autophagolysosomes. 
F I G U R E  7  Defective autophagosome maturation in a chronic mice‐smoking model. A/J mice were exposed to cigarette smoke (or fresh air) 
for 30 min/d for 12 days using Hi‐lite cigarettes. Lungs were removed and homogenized for immunoblotting. Western blot was performed and 
membranes were immune‐stained against p62 (B), LC3(C,D), BICD1 (E), and β‐actin. N1‐N4: Control mice, CS1‐CS4: smoking mice. Protein 
amounts were calculated against β‐actin and plotted in graphs. Data were analyzed by using t test. P < .05 was considered statistically significant.  
* P < .05, n = 4
   | 701MERCADO Et Al
We confirmed these findings using HEK293 cells that overex-
press the tandem GFP‐mCherry‐LC3 where lower concentra-
tions of CSE induced transient autophagosomes that became 
autophagolysosomes over time. This was not the case with 
higher concentrations of CSE where increased numbers of 
autophagosomes failed to become autophagolysosomes, sug-
gesting a mechanism where lysosomes fail to bind autophago-
somes. The different effects of differing concentrations of 
CSE on the autophagy machinery is cell‐dependent and might 
be dependent on how much the machinery can cope with oxi-
dative stress‐induced oxidized proteins and organelles which 
need to be degraded to maintain cellular homeostasis.
We have shown for the first time that BICD1 protein is 
significantly increased in both mild and severe COPD as 
compared to non‐COPD smokers, suggesting this increase is 
an early event in COPD. Also, increased BICD1 was associ-
ated with increased lung obstruction and markers of defec-
tive autophagosome maturation (LC3, p62, and p62 dimers). 
In vitro data using BEAS‐2Bs confirmed that only at a high 
concentration of CSE, which induces defective autophago-
some maturation, BICD1 protein was increased, alongside 
persistent LC3‐II and p62 expressions. It was also observed 
that CSE induced increased BICD1 transcript levels, and in-
hibition of transcription by actinomycin D prevented CSE‐
induced BICD1 mRNA expression, indicating increased 
transcription initiation by CSE as opposed to interference 
with RNA degradation mechanisms. These findings were 
supported by data obtained in primary bronchial epithelial 
F I G U R E  8  Cardiac glycosides reverse defective CSE‐induced defective autophagosome maturation. (A) BEAS‐2B cells were preincubated 
either with digoxin (D), digoxigenin (DG), and strophanthidin (SP) or with rapamycin for 6 hours before treatment with HC‐CSE for 24 h. Western 
blot was performed and membranes were immune‐stained against p62, BICD1, LC3, and β‐actin. (B) BEAS‐2B cells were preincubated with digoxin 
(D) for 2 h before a 4 h treatment with CQ. Cells were then treated with HC‐CSE for 24 h. Western blot was performed and membranes were immune‐
stained against p62, BICD1, LC3, and β‐actin (# p62 unspecific band detected). N = 3, *P < .05, **P < .01, ***P < .001, **** P < .0001.  
(C) BEAS‐2B cells were preincubated with digoxin (D) and then treated with HC‐CSE (10%) for 24 h. mRNA expression of BICD1 was determined 
and normalized to GNB2L1 mRNA levels. N = 3, **P < .01. (D) HBECs were preincubated with digoxin (D) at 1, 5, and 25 ng/mL prior to treatment 
with LC‐ (20%) and HC‐ (30%) CSE for 24 h. Western blot was performed and membranes were immune‐stained against p62, LC3, and β‐actin. (E) 
HBECs were preincubated with 25ng/mL of digoxin (D) prior to treatment with LC‐ (20%) and HC‐ (30%) CSE for 24 h. Western blot was performed 
and membranes were immune‐stained against BICD1 and β‐actin
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cells. Mice chronically exposed to CS also displayed in-
creased lung expression of BICD1, which also correlated with 
accumulation of p62 and total LC3. Knockdown of BICD1 
confirmed that CSE‐induced BICD1 is most likely responsi-
ble for an accumulation of p62 due to defective autophago-
some maturation. Overexpression of the C‐terminal domain 
of BICD1, which can interact with Rab6A (a protein involved 
in regulation of protein transport), but not with cytoplasmic 
dynein, has been shown to alter microtubule movement of 
Rab6A vesicles inducing an accumulation of these vesicles 
in the cell.20 Recent studies have suggested that BICD1 is 
unlikely to be involved in lysosome biogenesis or function, 
but plays an important role in the regulation of endosome 
trafficking of cargoes to the lysosome.22 An accumulation of 
BICD1 may alter normal trafficking of the autophagosome to 
the lysosome preventing fusion and resulting in impaired au-
tophagic flux. Our clinical data suggest that accumulation of 
BICD1 is an early event in COPD and our in vitro data sug-
gest that high concentrations of CSE can cause this accumu-
lation. The reason for the lower levels of BICD1 observed in 
non‐COPD smokers is not related to the smoking history that 
is similar between these groups. All non‐COPD except one 
were current smokers before lung samples were collected. It 
is possible that some individuals have a propensity to induce 
BICD1, which could deregulate the normal flux of autophagy 
thus accumulating cellular damage over time.
Inhibition of autophagy typically results in the accumu-
lation of p62, leading to the formation of large aggregates 
positive for p62 and ubiquitinated proteins.44 CSE‐induced 
p62 oligomer formation is possibly linked with aggresome 
formation previously observed in lung from COPD patients.2 
These oligomers might sequester autophagosomes and auto-
phagic cargo into structures physically too large to degrade, 
thus bloating the autophagy machinery, disrupting homeo-
stasis, and compromising viability. Formation of SDS‐re-
sistant p62 oligomers has previously been observed with 
arsenic exposure and in macrophages from smokers.33,45 
Both studies showed that p62 oligomers were associated 
with ubiquitinated substrates. More recently, Donohue et 
al34 showed that the autophagy inhibitor verteporfin induces 
p62 dimers via a mechanism involving low‐level singlet 
oxygen production. In fact hydrogen peroxide mimicked 
p62 dimer formation but without p62 monomer accumula-
tion.34 We confirmed that CSE induced p62 oligomers in a 
concentration‐ and time‐dependent manner. At low concen-
trations of CSE, p62 oligomers were transient, reflecting a 
functional increased autophagic flux. At higher CSE, p62 
oligomers were still present in the cells despite washing‐out 
CSE. Immunoprecipitation showed that p62 was heavily as-
sociated with ubiquitinated substrates after CSE treatment 
and that deubiquitination by USP2 did not affect oligomer 
formation. p62 was found to be associated with LC3‐II, as 
expected, but also with cytoplasmic LC3‐I. This is further 
proof that oligomers and LC3‐I might exist as aggresomes 
inside cells. CSE did not further enhance p62 association 
with the adaptor protein NBR1 and neither did it induce 
F I G U R E  9  Defective autophagosome maturation hypothesis in chronic obstructive pulmonary disease (COPD). In non‐COPD smokers, 
CSE induces ubiquitinated proteins that are recognized by p62 and driven toward LC3‐II‐containing double membranes. These double membranes 
close to become autophagosomes (APs) thus engulfing p62 with ubiquitinated proteins. APs then bind lysosomes (lys) in order to become 
autophagolysosomes (ALs) and degrade intracellular cargo via lysosomal hydrolases. In COPD, BICD1 accumulates due to excessive CSE 
exposure over a lifetime. Baseline or CSE‐induced autophagosomes accumulate due to BICD1 preventing autophagosome to lysosome fusion
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NBR1 SDS‐PAGE resistant oligomers. It is possible that 
p62 oligomers can affect the flux of autophagy. Donohue 
et al34 showed that oxidant‐induced p62 oligomers needed 
a functional PB1 domain, thus suggesting that previous ag-
gregation was necessary. We did not confirm these findings 
and identified the amino acid region of p62 most likely to be 
involved in oligomer formation as the KIR. Knockdown of 
Keap1 clearly decreased CSE‐induced oligomer formation 
and in A549 cells, which have mutant Keap1 that is unable 
to bind to p62, there were no oligomers after CSE exposure. 
Mutation of the KIR domain also reduced CSE‐induced 
oligomers. In fact, NBR1, which lacks a KIR domain, also 
failed to form oligomers. The exact reason as to why the in-
teraction of p62 with Keap1, which is based on hydrogen 
bonds, results in these oligomers is not yet understood.
Further proof that CSE induced defective autophagosome 
maturation was provided by cardiac glycosides. Two studies 
identified cardiac glycosides as potential compounds that 
induce autophagosome maturation.37,38 In addition, digoxin 
was also found to be able to induce autophagosomes via ac-
tivation of the AMPK pathway resulting in mTOR inhibi-
tion.46 We could not confirm that cardiac glycosides induce 
LC3‐II formation using an “LC3 turnover assay”; however, 
we showed how they reduced HC‐CSE‐induced p62 and p62 
oligomers suggesting that they target autophagosome matu-
ration. In contrast, an mTOR inhibitor, rapamycin, known to 
induce autophagosome formation, was unable to clear p62 
oligomers via autophagy. We also showed how cardiac glyco-
sides reduced BICD1 expression suggesting a mechanism by 
which autophagosome maturation is restored under HC‐CSE. 
Cardiac glycosides increase the level of calcium by inhibiting 
the Na+/K+‐ATPase, resulting in augmented contractile force 
in cardiomyocytes.47 In fact, intracellular calcium induces 
autophagy.48 The use of cardiac glycosides has been mainly 
suggested for cancer therapy, and their stimulatory effect on 
autophagy may be important in this context.49 Recently, car-
diac glycosides have been shown to inhibit Tat‐Beclin1‐in-
duced autophagic‐mediated cell death, known as autosis.50 
However, digoxin had no effect on staurosporine‐induced 
apoptotic death.50 We found that CSE‐induced cleaved 
caspase‐3 was reversed by cardiac glycosides, including di-
goxin, whereas rapamycin had no effect. Another cardiac gly-
coside, bufalin, can inhibit tumor necrosis factor (TNF), IFN, 
and CXCL‐8.51 These novel anti‐inflammatory effects could 
be related to the modulation of autophagic flux and thus rel-
evant to COPD that is associated with chronic inflammation 
and autoimmunity.12
We have identified BICD1 as novel candidate for defec-
tive autophagosome maturation and shown that in COPD, 
increased BICD1 levels could explain elevated levels of auto-
phagosomes and p62 (Figure 9). Previous research in COPD 
has also identified the presence of LC3‐II in lung tissue sug-
gestive of an activation of autophagosomes.6,8 However, these 
studies did not measure overall LC3, which also appeared to 
be increased, as well as p62 levels. The latter is known to 
negatively correlate with autophagy activation. Increased p62 
monomer and oligomer accumulation causes protein aggre-
gates that in turn could result in toxicity for cells as homeo-
stasis is compromised. In fact, protein aggregation, which 
has been observed in COPD patients, could be caused by 
defective autophagosome maturation as also observed in sev-
eral neurodegenerative diseases.2,7,40 We have also identified 
cardiac glycosides as compounds able to restore autophago-
some maturation. Thus, cardiac glycosides are possible tar-
get for novel drugs that can reverse defective autophagic flux 
and offer a potential future therapeutic approach in COPD. 
Further studies would be needed to establish which cell types 
in the lung of COPD patients are responsible for increased 
BICD1 expression and defective autophagosome maturation 
and follow‐up studies in GFP‐LC3 transgenic mice would be 
required to verify if cardiac glycosides do restore normal lev-
els of autophagy in a COPD model.
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